Stock Analysis

KB Financial Group Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Published
KOSE:A105560

KB Financial Group (KRX:105560) Second Quarter 2024 Results

Key Financial Results

  • Revenue: ₩20t (up 446% from 2Q 2023).
  • Net income: ₩1.73t (up 19% from 2Q 2023).
  • Profit margin: 8.7% (down from 40% in 2Q 2023). The decrease in margin was driven by higher expenses.
  • EPS: ₩4,526 (up from ₩3,776 in 2Q 2023).
KOSE:A105560 Earnings and Revenue Growth July 28th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

KB Financial Group EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 3.6%. Earnings per share (EPS) exceeded analyst estimates by 9.0%.

Looking ahead, revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Banks industry in South Korea.

Performance of the South Korean Banks industry.

The company's shares are up 3.7% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 1 warning sign for KB Financial Group that you need to be mindful of.

Valuation is complex, but we're here to simplify it.

Discover if KB Financial Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.